Clinical Trials Arena February 13, 2025
Deep learning methods are rapidly generating high-affinity protein binders in a way that would have been unimaginable even a decade ago. The consequences for drug discovery, synthetic biology and precision therapeutics will be profound.
With 2025 well underway, the runaway momentum of artificial intelligence (AI) looks unstoppable. GlobalData estimates that the total AI market will be worth over $1 trillion by 2030. As with many sectors, this rapid growth is already having a transformative impact in life sciences.
According to GlobalData’s Drugs database, there are over 3,000 drugs that have been developed or repurposed using AI as of the beginning of 2025. The majority are in early stages of development — either discovery or preclinical. Oncology is the leading therapy...
Today's Sponsors
Today's Sponsor